Effect of Jacobson's relaxation on anxiety in patients undergoing percutaneous coronary intervention
Authors
Abstract:
Introduction: Anxiety is common in patients undergoing percutaneous coronary intervention. Some studies have shown that one of the decreasing factors in anxiety is relaxation. Importantly, this study has been done with the aim of investigate the effect of Jacobson's relaxation on anxiety in patients undergoing percutaneous coronary intervention. Materials and Methods: In this double-blind clinical trial 56 patients undergoing percutaneous coronary intervention randomly assigned in to two test and control groups. Participants completed the state and trate anxiety Spilberberg questioner 50 minutes prior to the femoral Catheter outlet, then in test group, patients relaxed for 15 minutes. There was no intervention in the control group. In the two groups before the arterial catheter outlet, stat anxiety was measured again using Spilberger's state Anxiety Questionnaire. Results: There were no significant differences between the two groups regarding age, marital status, education, place of residence and health insurance status. Interestingly, the findings showed that the mean of trait anxiety had no difference in two groups. The mean of state anxiety in relaxation group before and after intervention had Statistical significant difference but there was no significant difference in control group. Conclusion: Remarkably, the results of this study showed that Jacobson's relaxation can reduce anxiety in patients undergoing coronary artery bypass grafting. Therefore, Jacobson's relaxation can be suggested as a non-invasive method to reduce the anxiety of patients before coronary intervention.
similar resources
Effect of Aromatherapy Massage on Anxiety among Patients Undergoing Percutaneous Coronary Intervention
Background and Objective: Percutaneous Coronary Intervention (PCI) is a common procedure in treatment of coronary artery diseases. Anxiety is a common psychological reaction to cardiovascular interventions. Anxiety can affect physiological responses and cause blood pressure increase, cardiac output decrease, cardiac o2 demand increase, and finally ischemic pain. The aim of this study was to ass...
full textClopidogrel Resistance and its Impact on Clinical Outcome of Iranian Patients Undergoing Percutaneous Coronary Intervention
The aim of current study was evaluating the frequency of clopidogrel resistance and its impact on clinical outcome of patients in Iranian patients. Patients undergoing percutaneous coronary intervention in Imam Hussein Medical center, Tehran, Iran, who received standard dosage of clopidogrel (Plavix®, Sanofi, France, 600 mg loading dose and 75 mg/day afterward) were recruited. Platelet aggregat...
full textClopidogrel Resistance and its Impact on Clinical Outcome of Iranian Patients Undergoing Percutaneous Coronary Intervention
The aim of current study was evaluating the frequency of clopidogrel resistance and its impact on clinical outcome of patients in Iranian patients. Patients undergoing percutaneous coronary intervention in Imam Hussein Medical center, Tehran, Iran, who received standard dosage of clopidogrel (Plavix®, Sanofi, France, 600 mg loading dose and 75 mg/day afterward) were recruited. Platelet aggregat...
full textAssociation of ABCB1 Gene Polymorphisms and Clopidogrel Responsiveness in Iranian Patients undergoing Percutaneous Coronary Intervention
Clopidogrel is an antiplatelet agent currently used for preventing stent thrombosis. Despite certain clinical benefits of clopidogrel in patients undergoing percutaneous coronary intervention (PCI), adequate antiplatelet effect has not been obtained in some patients. The present study was designed to investigate the potential association of ABCB1 (ATP-Binding Cassette, Subfamily B, member1) gen...
full textAssociation of ABCB1 Gene Polymorphisms and Clopidogrel Responsiveness in Iranian Patients undergoing Percutaneous Coronary Intervention
Clopidogrel is an antiplatelet agent currently used for preventing stent thrombosis. Despite certain clinical benefits of clopidogrel in patients undergoing percutaneous coronary intervention (PCI), adequate antiplatelet effect has not been obtained in some patients. The present study was designed to investigate the potential association of ABCB1 (ATP-Binding Cassette, Subfamily B, member1) gen...
full textEvaluation of ejection fraction in patients with acute myocardial infarction undergoing percutaneous coronary intervention
Introduction: Percutaneous coronary intervention (PCI) is a reperfusion strategy to increase life expectancy and ejection fraction (EF) in ST-segment elevation myocardial infarction (STEMI) patients. We investigated the effect of location, severity, type of lesion, number and type of vessel involved and time of angioplasty on the increase in EF in STEMI patients undergoing primary PCI (P-PCI) a...
full textMy Resources
Journal title
volume 21 issue 4
pages 628- 632
publication date 2019-09
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023